The effect of clomiphene citrate on oxidative stress parameters in polycystic ovarian syndrome

References

• Adashi EY. 1984. Clomiphene citrate: mechanism(s) and site(s) of action. A hypothesis revisited. Fertility and Sterility 42:331–344.
   PubMed Web of Science ®Google Scholar
• Advani K, Batra M, Tajpuriya S, Gupta R, Saraswat A, Nagar HD, et al. 2019. Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study. Journal of Obstetrics and Gynaecology 40:96–101.
   Web of Science ®Google Scholar
• Agacayak E, Tunc SY, Sak S, Basaranoglu S, Yüksel H, Turgut A, Gul T. 2015. Levels of neopterin and other inflammatory markers in obese and non-obese patients with polycystic ovary syndrome. Medical Science Monitor 21:2446–2455.
   PubMed Web of Science ®Google Scholar
• Anatoliotakis N, Deftereos S, Bouras G, Giannopoulos G, Tsounis D, Angelidis C, et al. 2013. Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease. Current Topics in Medicinal Chemistry 13:115–138.
   PubMed Web of Science ®Google Scholar
• Bradley PP, Priebat DA, Christensen RD, Rothstein G. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. Journal of Investigative Dermatology 78:206–209.
   PubMed Web of Science ®Google Scholar
• Çetin M, Tunçdemir P, Karaman K, Yel S, Karaman E, Özgökçe M, Kömüroğlu AU. 2019. Cardiovascular evaluation and serum paraoxonase-1 levels in adolescents with polycystic ovary syndrome. American Journal of Obstetrics and Gynecology 40:90–95.
   Web of Science ®Google Scholar
• Dumesic DA, Meldrum DR, Katz-Jaffe MG, Krisher RL, Schoolcraft WB. 2015. Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health. Fertility and Sterility 103:303–316.
   PubMed Web of Science ®Google Scholar
• Erel O. 1998. Automated measurement of serum ferroxidase activity. Clinical Chemistry 44: 2313–2319.
   PubMed Web of Science ®Google Scholar
• Fauser BCJM. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81:19–25.
   Web of Science ®Google Scholar
• Halliwell B. 1994. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?. The Lancet 344:721–724.
   PubMed Web of Science ®Google Scholar
• Homburg R. 2005. Clomiphene citrate–end of an era? A mini-review. Human Reproduction 20: 2043–2051.
   PubMed Web of Science ®Google Scholar
• Hosen MB, Islam MR, Begum F, Kabir Y, Howlader MZH. 2015. Oxidative stress induced sperm DNA damage, a possible reason for male infertility. Iranian Journal of Reproductive Medicine 13:525–532.
   PubMedGoogle Scholar
• Klebanoff SJ. 2005. Myeloperoxidase: friend and foe. J Leukoc Biol 77:598–628.
   PubMed Web of Science ®Google Scholar
• Kurdoglu Z, Ozkol H, Kurdoglu M. 2012. Serum myeloperoxidase and adenosine deaminase activities in polycystic ovary syndrome. Gynecological Endocrinology 28:115–118.
   PubMed Web of Science ®Google Scholar
• Kuşçu NK, Var A. 2009. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstetricia et Gynecologica Scandinavica 88:612–617.
   PubMed Web of Science ®Google Scholar
• Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK, et al., 2013. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism 98:4565–4592.
   PubMed Web of Science ®Google Scholar
• Moti M, Amini L, Ardakani SSM, Kamalzadeh S, Masoomikarimi M, Jafarisani M. 2015. Oxidative stress and anti-oxidant defense system in Iranian women with polycystic ovary syndrome. Iranian Journal of Reproductive Medicine 13:373–378.
   PubMedGoogle Scholar
• Norman RJ, Dewailly D, Legro RS, Hickey TE. 2007. Polycystic ovary syndrome. The Lancet 370:685–697.
   PubMed Web of Science ®Google Scholar
• Özer A, Bakacak M, Kiran H, Ercan Ö, Köstü B, Kanat-Pektaş M, et al. 2016. Increased oxidative stress is associated with insulin resistance and infertility in polycystic ovary syndrome. Ginekologia Polska 87:733–738.
   PubMed Web of Science ®Google Scholar
• Pabuçcu R, Orhan E, Ülgenalp İ, Atay V, Duru NK. 1992. Klomifen Sitrat’a Dirençli bir Polikistik Over Sendromu Olgusunda Düşük Doz Pürifie FSH ile Başarılı bir Ovulasyon İndüksiyonu. American Journal of Obstetrics and Gynecology 2:286–294.
   Google Scholar
• Qiao J, Feng HL. 2011. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Human Reproduction Update 17: 17–33.
   PubMed Web of Science ®Google Scholar
• Ruder EH, Hartman TJ, Blumberg J, Goldman MB. 2008. Oxidative stress and antioxidants: exposure and impact on female fertility. Human Reproduction Update 14:345–357.
   PubMed Web of Science ®Google Scholar
• Sabouhi Zarafshan S, Salehi Z, Salahi E, Sabet EE, Shabanipour S, Zahiri Z. 2015. Polymorphism of catalase gene (CAT C-262T) in women with endometriosis. Journal of Obstetrics and Gynaecology 35: 269–271.
   Web of Science ®Google Scholar
• Sabuncu T, Vural H, Harma M, Harma M. 2001. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clinical Biochemistry 34:407–413.
   PubMed Web of Science ®Google Scholar
• Sasıkala SL, Shamıla S, Nagarajan S, Nısha JC, Geetha P, Raj Kishor S. 2010. A comparative study of Ashokarishtam and clomiphere citrate in combating polycystic ovary syndrome induced oxidative stress in rat. J Cell Tissue Res 10:2105–2108.
   Google Scholar
• Shahrokhi SA, Naeini AA. 2019. The association between dietary antioxidants, oxidative stress markers, abdominal obesity and poly-cystic ovary syndrome: a case control study. Journal of Obstetrics and Gynaecology 40:77–82.
   Web of Science ®Google Scholar
• Tavaniotou A, Albano C, Smitz J, Devroey P. 2002. Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist. Fertility and Sterility 77:733–737.
   PubMed Web of Science ®Google Scholar
• Tümentemur G, Altunkaynak BZ, Kaplan S. 2019. Is melatonin, leptin or their combination more effective on oxidative stress and folliculogenesis in the obese rats? J Obstet Gynaecol, 40:1–12.
   PubMedGoogle Scholar
• Turan V, Sezer ED, Zeybek B, Sendag F. 2015. Infertility and the presence of insulin resistance are associated with increased oxidative stress in young, non-obese Turkish Women with polycystic ovary syndrome. Journal of Pediatric and Adolescent Gynecology 28:119–123.
   PubMed Web of Science ®Google Scholar
• Yildirim E, Derici MK. 2019. A case-control study on the oxidative status in women with polycystic ovary syndrome treated with clomiphene citrate. Medical Science Monitor 25:3910–3917.
   PubMed Web of Science ®Google Scholar
• Yilmaz M, Bukan N, Ayvaz G, Karakoç A, Törüner F, Çakir N, Arslan M, 2005. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Human Reproduction 20:3333–3340.
   PubMed Web of Science ®Google Scholar